Sunshine Lake Pharma Co., Ltd.

HK$38.80As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6887Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 4.09%
Div yield —
ROE (8.23%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM —
TSR TTM (15.28%)
Mkt cap HK$22.32B
ROIC 0.94%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$37
(3.63%)
(93.13%)
Hold 6|10|5|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.90
0.94
1.00
0.96
18.61%
15.11%
27.60%
18.93%
Revenue¥B
1.032
1.032
1.034
1.095
(1.75%)
(3.22%)
(2.23%)
3.15%
Peers (US$2.848B)
Cap (US$)
PE
2.848B
8.279x
Capital
TTM
5Y
10Y
Leveragex
0.591
(0.073)
(0.075)
EBIT/Intx
0.917
0.094
0.086
Own earn%
493.62
(198.74)
(208.30)
Sh yield%
45.24
13.50
15.57
Owners
Insiders/Inst%
12.22
51.41
Short interest%
2.34
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
10–13
$1 testx
1.1
Incr. ROIC%
6